- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 339-353 of
645 results
1546 Exhibit: Valeant Pharmaceuticals Under Investigation by Federal Prosecutors
Document
IPR2017-00190, No. 1546-195 Exhibit - Valeant Pharmaceuticals Under Investigation by Federal Prosecutors (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
2020 Exhibit: Kaken Exhibit 2020
Document
IPR2017-00190, No. 2020-66 Exhibit - Kaken Exhibit 2020 (P.T.A.B. Feb. 2, 2017)
|
|
Cite Document
1040 Exhibit: Walters, KA, J Pharm Pharmacol 35 28 33 1983
Document
IPR2017-00190, No. 1040-40 Exhibit - Walters, KA, J Pharm Pharmacol 35 28 33 1983 (P.T.A.B. Nov. 2, 2016)
|
|
Cite Document
1604 Exhibit: Valeant Pharmaceuticals International, Inc, US Securities and Excha...
Document
IPR2017-00190, No. 1604-253 Exhibit - Valeant Pharmaceuticals International, Inc, US Securities and Exchange Commission Form 10 K, for the Fiscal Year Ended December 31, 2012 (P.T.A.B....
|
|
Cite Document
2019 Exhibit: Kaken Exhibit 2019
Document
IPR2017-00190, No. 2019-65 Exhibit - Kaken Exhibit 2019 (P.T.A.B. Feb. 2, 2017)
|
|
Cite Document
2025 Exhibit: Kaken Exhibit 2025
Document
IPR2017-00190, No. 2025-72 Exhibit - Kaken Exhibit 2025 (P.T.A.B. Aug. 1, 2017)
|
|
Cite Document
2058 Exhibit: Kaken Exhibit 2058
Document
IPR2017-00190, No. 2058-105 Exhibit - Kaken Exhibit 2058 (P.T.A.B. Aug. 1, 2017)
|
|
Cite Document
2062 Exhibit: Kaken Exhibit 2062
Document
IPR2017-00190, No. 2062-108 Exhibit - Kaken Exhibit 2062 (P.T.A.B. Aug. 1, 2017)
|
|
Cite Document
1005 Exhibit: Declaration of Kenneth Walters
Document
IPR2017-00190, No. 1005-5 Exhibit - Declaration of Kenneth Walters (P.T.A.B. Nov. 2, 2016)
|
|
Cite Document
1599 Exhibit: Dow Pharmaceutical Sciences Becomes Wholly Owned Subsidiary as...
Document
IPR2017-00190, No. 1599-248 Exhibit - Dow Pharmaceutical Sciences Becomes Wholly Owned Subsidiary as Acquisition by Valeant Pharmaceuticals International is Completed (P.T.A.B. Nov. 1...
|
|
Cite Document
1640 Exhibit: Top 200 Brand Name Drugs by Retail Sales in 2002
Document
IPR2017-00190, No. 1640-289 Exhibit - Top 200 Brand Name Drugs by Retail Sales in 2002 (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
1574 Exhibit: Valeant Pharmaceuticals International, Inc 2Q 17 Financial Results P...
Document
IPR2017-00190, No. 1574-223 Exhibit - Valeant Pharmaceuticals International, Inc 2Q 17 Financial Results Presentation (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
1622 Exhibit: Promotion and Market Share in the Proton Pump Inhibitor Market A C...
Document
IPR2017-00190, No. 1622-271 Exhibit - Promotion and Market Share in the Proton Pump Inhibitor Market A Case Study (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
1502 Exhibit: Trends in the management of cutaneous fungal infections
Document
IPR2017-00190, No. 1502-148 Exhibit - Trends in the management of cutaneous fungal infections (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
1576 Exhibit: Thomas Reuters StreetEvents, Edited Transcript, VRXTO ¿¿¿ Q4 2015...
Document
IPR2017-00190, No. 1576-225 Exhibit - Thomas Reuters StreetEvents, Edited Transcript, VRXTO ¿¿¿ Q4 2015 Valeant Pharmaceuticals International Inc Earnings Call (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
